Somatic MED12 Mutations in Myometrial Cells.

Abstract excerpt

Over 70% of leiomyoma (LM) harbor MED12 mutations, primarily in exon 2 at c.130-131 (GG). Myometrial cells are the cell origin of leiomyoma, but the MED12 mutation status in non-neoplastic myometrial cells is unknown. In this study, we investigated the mutation burden of MED12 in myometrium. As traditional Sanger or even NGS sequencing may not be able to detect MED12 mutations that are lower than 0.1% in the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Exons
• Share to High-Throughput Nucleotide Sequencing
• Share to Leiomyoma